查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1615027

德國麻疹診斷測試全球市場報告（2024 年）

Rubella Diagnostic Testing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

德國麻疹診斷測試的市場規模預計在未來幾年將強勁成長。到 2028 年，將以 6.6% 的複合年成長率 (CAGR) 成長至 16.8 億美元。預測期內的預期成長是由於多種因素造成的，包括醫療保健成本增加、對預防保健的日益關注、對疫苗可預防疾病的認知提高、公共衛生宣傳活動的擴大以及遠端醫療和遠距離診斷的成長。在此期間預計的主要趨勢包括診斷技術的進步、技術與醫療保健系統的整合、照護現場檢測解決方案的開發、新診斷方法的引入以及分子診斷的改進。

病毒感染疾病的日益流行預計將在未來幾年推動德國麻疹診斷測試市場的成長。病毒感染疾病是由病毒引起的疾病，病毒是只能在宿主生物體的活細胞內複製的小型傳染原。病毒感染疾病的增加是由於全球旅行的增加導致病毒迅速跨境傳播，以及氣候變遷改變了病媒棲息地並擴大了攜帶疾病的生物體的分佈。德國麻疹診斷檢測對於早期發現和管理德國麻疹感染、預防併發症（尤其是孕婦）以及促進疫情控制以盡量減少病毒傳播至關重要。例如，2023年12月，英國政府機構國民健康服務報告稱，平均每天有234人因流感住院，比前一周增加了53%。此外，諾羅病毒住院人數增加了15%，達到平均每天406人，與去年同週相比增加了28%。因此，病毒感染病例數量的增加正在推動德國麻疹診斷測試市場的成長。

德國麻疹診斷測試市場的主要企業正專注於開發德國麻疹病毒疫苗等創新解決方案，以提高診斷準確性並加強預防措施。德國麻疹病毒疫苗可提供針對德國麻疹的免疫力，並且通常包含在 MMR 和 MMRV 聯合疫苗中以預防該疾病及其併發症。例如，2023年3月，美國製藥公司默克公司推出了肌肉注射（IM）MMR II疫苗，該核准不僅對預防德國德國麻疹至關重要，而且對預防麻疹和流行性腮腺炎。此次核准允許醫療保健提供者透過 IM 途徑注射德國麻疹疫苗，並將其與其他常規建議的兒科疫苗放在一起。接種德國麻疹疫苗對於預防風疹爆發和預防德國麻疹病毒可能引起的嚴重併發症非常重要，特別是對於孕婦。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球德國麻疹診斷檢測市場的驅動與限制因素
    • 市場驅動力
    • 市場限制
  • 2018-2023年全球德國麻疹診斷測試市場規模與成長表現
  • 2023-2028年、2033年全球德國麻疹診斷測試市場規模及成長預測

第6章 市場細分

  • 全球德國麻疹診斷檢測市場，依診斷技術、效能及預測分類，2018-2023年、2023-2028年、2033年
  • 乳膠凝集測試
  • 肝功能檢查
  • 酵素免疫分析法（EIA）
  • 免疫測量（Ria）
  • 螢光免疫分析(FIA)
  • 其他診斷技術
  • 全球德國麻疹診斷檢測市場，依年齡層、表現及預測，2018-2023、2023-2028、2033
  • 新生
  • 青少年
  • 成人
  • 全球德國麻疹診斷測試市場，按最終用戶、效能和預測，2018-2023、2023-2028、2033
  • 醫院/診所
  • 癌症診斷中心
  • 門診手術中心
  • 其他最終用戶

第7章 地區/國家分析

  • 全球德國麻疹診斷檢測市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球德國麻疹診斷檢測市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 德國麻疹診斷檢測市場的競爭狀況
  • 德國麻疹診斷測試市場公司概況
    • Cardinal Health Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd

第31章 其他大型創新企業

  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Ortho-Clinical Diagnostics Inc.
  • DiaSorin SpA
  • Meridian Bioscience Inc.
  • Fortress Diagnostics Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • MP Biomedicals LLC
  • CTK Biotech Inc.
  • ZEUS Scientific Inc.
  • Creative Diagnostics
  • Arlington Scientific Inc.
  • AccuBioTech Co. Ltd.
  • Intec Products Inc.
  • Vitrosens Biotechnology Ltd.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r20351

Rubella diagnostic testing involves methods used to detect the presence of the rubella virus or antibodies in a patient's blood, confirming whether they have been infected with rubella or possess immunity against it. These tests enable healthcare providers to accurately diagnose rubella and manage its implications, particularly for vulnerable populations.

The primary types of diagnostic techniques used in rubella testing include latex agglutination, liver function tests, enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescent immunoassay (FIA), and others. Latex agglutination is a diagnostic approach where small latex beads coated with rubella-specific antigens or antibodies are mixed with a patient's sample. This technique can be applied across various age groups, including neonates, teenagers, and adults, serving a wide range of end users such as hospitals, clinics, cancer diagnostic centers, and ambulatory surgical centers.

The rubella diagnostic testing market research report is one of a series of new reports from The Business Research Company that provides rubella diagnostic testing market statistics, including rubella diagnostic testing industry global market size, regional shares, competitors with a rubella diagnostic testing market share, detailed rubella diagnostic testing market segments, market trends and opportunities, and any further data you may need to thrive in the rubella diagnostic testing industry. This rubella diagnostic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The rubella diagnostic testing market size has grown strongly in recent years. It will grow from $1.22 billion in 2023 to $1.30 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to factors such as the increase in vaccination programs, a rise in the incidence of immunization-preventable outbreaks, government initiatives aimed at combating the rubella virus, and the expansion of diagnostic testing in non-traditional settings.

The rubella diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to several factors, including increasing healthcare expenditures, a growing emphasis on preventive healthcare, rising awareness of vaccine-preventable diseases, expanded public health campaigns, and the growth of telemedicine and remote diagnostics. Key trends expected during this period include advancements in diagnostic technologies, the integration of technology within healthcare systems, the development of point-of-care testing solutions, the introduction of new diagnostic methods, and improvements in molecular diagnostics.

The increasing incidence of viral infections is anticipated to drive the growth of the rubella diagnostic testing market in the future. Viral infections are illnesses caused by viruses, which are tiny infectious agents that can only replicate within the living cells of a host organism. The rise in viral infections can be attributed to heightened global travel, which allows for the rapid spread of viruses across borders, as well as climate change, which modifies vector habitats and expands the distribution of disease-carrying organisms. Rubella diagnostic testing is crucial for early identification and management of rubella infections, helping to prevent complications, especially in pregnant women, and facilitating outbreak control to minimize virus transmission. For instance, in December 2023, the National Health Service, a UK government department, reported an average of 234 daily hospital admissions for flu, representing a 53% increase from the previous week. Additionally, hospital cases of norovirus rose by 15%, averaging 406 daily, which is a 28% increase compared to the same week last year. Consequently, the increasing cases of viral infections are propelling the growth of the rubella diagnostic testing market.

Key companies in the rubella diagnostic testing market are concentrating on developing innovative solutions, such as rubella virus vaccines, to improve diagnostic accuracy and enhance preventive measures. The rubella virus vaccine provides immunity against rubella and is often included in the MMR or MMRV combination vaccines to prevent the disease and its complications. For example, in March 2023, Merck & Co., Inc., a U.S.-based pharmaceutical company, received FDA approval for the intramuscular (IM) administration of its M-M-R II vaccine, which is essential for protecting against rubella, as well as measles and mumps. This approval enables healthcare providers to administer the rubella vaccine via the IM route, aligning it with other routinely recommended pediatric vaccines. Vaccination against rubella is critical for preventing outbreaks and safeguarding against the severe complications that the virus can inflict, particularly in pregnant women.

In September 2024, Leinco Technologies Inc., a U.S.-based developer of high-purity antibodies, acquired QED Biosciences for an undisclosed sum. This acquisition aims to expand Leinco Technologies' antibody product portfolio and development services, enhancing its capabilities in life sciences and in vitro diagnostics while supporting its growth strategy and commitment to innovation and quality for researchers worldwide. QED Biosciences specializes in developing novel monoclonal and polyclonal antibody products and offers rubella diagnostic testing services.

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMerieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

North America was the largest region in the rubella diagnostic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rubella diagnostic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rubella diagnostic testing market consists of revenues earned by entities by providing services such as serological testing services, serologic tests, molecular diagnostic services, and rapid diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rubella diagnostic testing market also includes sales of serological assays, IgM antibodies, rapid diagnostic tests (RDTs), and polymerase chain reaction (PCR) tests. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rubella Diagnostic Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rubella diagnostic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for rubella diagnostic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rubella diagnostic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Diagnostic Technique: Latex Agglutination; Liver Function Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (Ria); Fluorescent Immunoassay (FIA); Other Diagnostic Techniques
  • 2) By Age Group: Neonates; Teenagers; Adults
  • 3) By End User: Hospitals And Clinics; Cancer Diagnostic Centers; Ambulatory Surgical Centers; Other End Users
  • Companies Mentioned: Cardinal Health Inc.; Siemens Healthineers AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Rubella Diagnostic Testing Market Characteristics

3. Rubella Diagnostic Testing Market Trends And Strategies

4. Rubella Diagnostic Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Rubella Diagnostic Testing Market Size and Growth

  • 5.1. Global Rubella Diagnostic Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Rubella Diagnostic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Rubella Diagnostic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Rubella Diagnostic Testing Market Segmentation

  • 6.1. Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Latex Agglutination
  • Liver Function Tests
  • Enzyme Immunoassay (EIA)
  • Radioimmunoassay (Ria)
  • Fluorescent Immunoassay (FIA)
  • Other Diagnostic Techniques
  • 6.2. Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Neonates
  • Teenagers
  • Adults
  • 6.3. Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Cancer Diagnostic Centers
  • Ambulatory Surgical Centers
  • Other End Users

7. Rubella Diagnostic Testing Market Regional And Country Analysis

  • 7.1. Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Rubella Diagnostic Testing Market

  • 8.1. Asia-Pacific Rubella Diagnostic Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Rubella Diagnostic Testing Market

  • 9.1. China Rubella Diagnostic Testing Market Overview
  • 9.2. China Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Rubella Diagnostic Testing Market

  • 10.1. India Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Rubella Diagnostic Testing Market

  • 11.1. Japan Rubella Diagnostic Testing Market Overview
  • 11.2. Japan Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Rubella Diagnostic Testing Market

  • 12.1. Australia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Rubella Diagnostic Testing Market

  • 13.1. Indonesia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Rubella Diagnostic Testing Market

  • 14.1. South Korea Rubella Diagnostic Testing Market Overview
  • 14.2. South Korea Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Rubella Diagnostic Testing Market

  • 15.1. Western Europe Rubella Diagnostic Testing Market Overview
  • 15.2. Western Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Rubella Diagnostic Testing Market

  • 16.1. UK Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Rubella Diagnostic Testing Market

  • 17.1. Germany Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Rubella Diagnostic Testing Market

  • 18.1. France Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Rubella Diagnostic Testing Market

  • 19.1. Italy Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Rubella Diagnostic Testing Market

  • 20.1. Spain Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Rubella Diagnostic Testing Market

  • 21.1. Eastern Europe Rubella Diagnostic Testing Market Overview
  • 21.2. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Rubella Diagnostic Testing Market

  • 22.1. Russia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Rubella Diagnostic Testing Market

  • 23.1. North America Rubella Diagnostic Testing Market Overview
  • 23.2. North America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Rubella Diagnostic Testing Market

  • 24.1. USA Rubella Diagnostic Testing Market Overview
  • 24.2. USA Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Rubella Diagnostic Testing Market

  • 25.1. Canada Rubella Diagnostic Testing Market Overview
  • 25.2. Canada Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Rubella Diagnostic Testing Market

  • 26.1. South America Rubella Diagnostic Testing Market Overview
  • 26.2. South America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Rubella Diagnostic Testing Market

  • 27.1. Brazil Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Rubella Diagnostic Testing Market

  • 28.1. Middle East Rubella Diagnostic Testing Market Overview
  • 28.2. Middle East Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Rubella Diagnostic Testing Market

  • 29.1. Africa Rubella Diagnostic Testing Market Overview
  • 29.2. Africa Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Rubella Diagnostic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Rubella Diagnostic Testing Market Competitive Landscape
  • 30.2. Rubella Diagnostic Testing Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Siemens Healthineers AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche Ltd
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Rubella Diagnostic Testing Market Other Major And Innovative Companies

  • 31.1. bioMerieux S.A.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Ortho-Clinical Diagnostics Inc.
  • 31.4. DiaSorin S.p.A.
  • 31.5. Meridian Bioscience Inc.
  • 31.6. Fortress Diagnostics Ltd.
  • 31.7. Mylab Discovery Solutions Pvt. Ltd.
  • 31.8. MP Biomedicals LLC
  • 31.9. CTK Biotech Inc.
  • 31.10. ZEUS Scientific Inc.
  • 31.11. Creative Diagnostics
  • 31.12. Arlington Scientific Inc.
  • 31.13. AccuBioTech Co. Ltd.
  • 31.14. Intec Products Inc.
  • 31.15. Vitrosens Biotechnology Ltd.

32. Global Rubella Diagnostic Testing Market Competitive Benchmarking

33. Global Rubella Diagnostic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Rubella Diagnostic Testing Market

35. Rubella Diagnostic Testing Market Future Outlook and Potential Analysis

  • 35.1 Rubella Diagnostic Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Rubella Diagnostic Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Rubella Diagnostic Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer